Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies
Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320)
10/2005
10/27/2005WO2005100405A2 Phosphorylcholine conjugates and corresponding antibodies
10/27/2005WO2005100404A1 Prostate cancer diagnosis and treatment
10/27/2005WO2005100403A2 Antibodies to erythropoietin receptor and uses thereof
10/27/2005WO2005100402A1 Anti-p-selectin antibodies
10/27/2005WO2005100401A2 Monoclonal antibodies with specificity for fetal erythroid cells
10/27/2005WO2005100400A1 Humanized antibody against s-surface antigen of hepatitis b virus
10/27/2005WO2005100399A2 Dr5 antibodies and uses thereof
10/27/2005WO2005100398A1 Method of preparing antibody library
10/27/2005WO2005100391A1 Diagnosis of inflammatory bowel diseases, more particularly ulcerative colitis
10/27/2005WO2005100389A1 Osteoblast growth factor
10/27/2005WO2005099776A2 Steroid sparing agents and methods of using same
10/27/2005WO2005099756A2 ErbB ANTAGONISTS FOR PAIN THERAPY
10/27/2005WO2005099755A2 Methods of treating autoimmune and inflammatory diseases
10/27/2005WO2005099753A1 Anti-gluten egg yolk antibodies for the treatment of celiac disease
10/27/2005WO2005099746A1 Method for modulating appetite
10/27/2005WO2005099361A2 MHC CLASS I - PEPTIDE-ANTIBODY CONJUGATES WITH MODIFIED β2-MICROGLOBULIN
10/27/2005WO2005089524A9 Compositions and methods for detection of single molecules
10/27/2005WO2005082939A3 Anti-abeta antibody
10/27/2005WO2005073254A3 Methods for inhibiting squamous cell carcinoma using antibodies against laminin
10/27/2005WO2005063819A3 Human binding molecule against cd1a
10/27/2005WO2005063335B1 MONOCLONAL DES-LYS58-β2-MICROGLOBULIN ANTIBODIES FOR MEASUREMENT AND MANAGEMENT OF HEMODIALYSIS COMPLICATIONS
10/27/2005WO2005060642A3 Rationally designed antibodies
10/27/2005WO2005060375A3 Methods of therapy and diagnosis using targeting of cells that express killer cell immunoglobulin-like receptor-like protein
10/27/2005WO2005052000A3 Anti-il-20 antibodies and binding partners and methods of using in inflammation
10/27/2005WO2005040338A3 Constrained alkaloid immunogens and antibodies and uses thereof
10/27/2005WO2005037854A3 Immunogenic peptides
10/27/2005WO2005023299A3 Therapeutic human anti-mhc class ii antibodies and their uses
10/27/2005WO2005012531A3 Antibody cdr polypeptide sequences with restricted diversity
10/27/2005WO2005007699A8 Human antibody molecules for il-13
10/27/2005WO2004101740A3 Clotting factor-fc chimeric proteins to treat hemophilia
10/27/2005WO2004094598A3 Methods of use for novel human polypeptides encoded by polynucleotides
10/27/2005WO2003023008A8 Therapeutic polypeptides, nucleic acids encoding same, and methods of use
10/27/2005US20050241023 Transgenic plants expressing assembled secretory antibodies
10/27/2005US20050241006 Human antibodies derived from immunized xenomice
10/27/2005US20050240012 Bispecific molecules for use in inducing antibody dependent effector cell-mediated cytotoxicity
10/27/2005US20050240006 Cytoplasmic region with more than 107 or less than 104 amino acids, a transmembrance region, and an extracellular region; nucleic acids and antibodies; diagnosing hematopoietic cell malignancy or autoimmune disease
10/27/2005US20050239700 Treatment of cancer using antibodies to LRRC15
10/27/2005US20050239215 Method for quantitatively detecting antigen
10/27/2005US20050239169 Nucleotide sequences coding seladin-1polypeptide for use in treatment and prevention of alzheimer's disease
10/27/2005US20050239168 Detecting moderators of kinase peptide; encoding genes
10/27/2005US20050239167 Fusion polypeptides of human serum albumin and a therapeutically active polypeptide
10/27/2005US20050239163 Cloning, expression and functional characterization of a mammalian DNA-R gene; polypetide having amino acid sequence with deletion at 1133 1171 amino acids
10/27/2005US20050239143 Immunocapture-based measurements of mammalian pyruvate dehydrogenase complex
10/27/2005US20050239141 Modified antibody variable domains
10/27/2005US20050239136 Risk markers for cardiovacular disease
10/27/2005US20050239131 Interactive system for presenting and eliminating substances
10/27/2005US20050239130 Method for identifying a modulator of the binding of CCX CKR polypeptide to a chemokine
10/27/2005US20050239103 Flea head, nerve cord, hindgut and malpighian tubule nucleic acid molecules, proteins and uses thereof
10/27/2005US20050239099 27 human secreted proteins
10/27/2005US20050239081 Polymerase enhancing factor (PEF) extracts, PEF protein complexes, isolated PEF protein, and methods for purifying and identifying
10/27/2005US20050239064 Methods and compositions based on protein interactions with mastermind
10/27/2005US20050239058 Method for the detection, identification, enumeration and confirmation of virally infected cells and other epitopically defined cells in whole blood
10/27/2005US20050239052 Cloning of rhadinovirus genome and methods for its use
10/27/2005US20050238689 Bioactive stents for type II diabetics and methods for use thereof
10/27/2005US20050238665 Soluble recombinant botulinum toxin proteins
10/27/2005US20050238656 Recombinant vesiculoviruses and their uses
10/27/2005US20050238652 Human lung adenocarcinoma-related monoclonal antibody and antigen and immunaossay method which uses the same
10/27/2005US20050238650 Compositions and methods for the treatment of tumor of hematopoietic origin
10/27/2005US20050238649 Monomethylvaline compounds capable of conjugation to ligands
10/27/2005US20050238648 Composition and method for trating inflammatory disorders
10/27/2005US20050238647 Therapeutic uses for MDC and MDC antagonists
10/27/2005US20050238646 Binding domain-immunoglobulin fusion proteins
10/27/2005US20050238644 Preventive and/or therapeutic agent for systemic lupus erythematosus comprising anti-lL-6 receptor antibody as an active ingredient
10/27/2005US20050238643 Modulation of lir function to treat rheumatoid arthritis
10/27/2005US20050238642 Modified bouganin proteins, cytotoxins and methods and uses thereof
10/27/2005US20050238640 Treatment with anti-ErbB2 antibodies and EGFR-targeted drugs
10/27/2005CA2776927A1 Phosphorylcholine conjugates and corresponding antibodies
10/27/2005CA2606138A1 Prostate cancer diagnosis and treatment
10/27/2005CA2564129A1 Dr5 antibodies and uses thereof
10/27/2005CA2564119A1 Methods of obtaining optically active epoxides and vicinal diols from styrene oxides
10/27/2005CA2563578A1 Diagnostic and therapeutic applications of soluble lhcgr protein
10/27/2005CA2563341A1 Erbb antagonists for pain therapy
10/27/2005CA2563295A1 Antibodies to erythropoietin receptor and uses thereof
10/27/2005CA2563260A1 Methods of treating autoimmune and inflammatory diseases
10/27/2005CA2562881A1 Novel monkey gpr103 and monkey qrfp and method of evaluating compound by using gpr103
10/27/2005CA2562550A1 Phosphorylcholine conjugates and corresponding antibodies
10/27/2005CA2561877A1 Use of mic-1 or modulating agent thereof to modulate appetite or body weight
10/27/2005CA2561830A1 Monoclonal antibodies with specificity for fetal erythroid cells
10/27/2005CA2561533A1 Anti-p-selectin antibodies
10/27/2005CA2561364A1 Steroid sparing agents and methods of using same
10/27/2005CA2559870A1 Mass spectrometry of antibody conjugates
10/26/2005EP1589115A2 Polymorphisms of the human organic anion transporting polypeptide-C (OATP-C)
10/26/2005EP1589107A1 Immunoglobulins devoid of light chains
10/26/2005EP1589100A1 Transcriptional activator
10/26/2005EP1589034A2 Rationally designed antibodies
10/26/2005EP1589033A1 Antibody and use thereof
10/26/2005EP1588712A1 Modulators of regulatory proteins
10/26/2005EP1588167A2 Sperm specific lysozyme-like proteins
10/26/2005EP1588166A2 Dual expression vector system for antibody expression in bacterial and mammalian cells
10/26/2005EP1588142A2 Methods for diagnosing rcc and other solid tumors
10/26/2005EP1587921A2 Fusion constructs and use of same to produce antibodies with increased fc receptor binding affinity and effector function
10/26/2005EP1587838A2 Therapeutic polypeptides, homologues thereof, fragments thereof and for use in modulating platelet-mediated aggregation
10/26/2005EP1587837A2 Prostate cancer diagnosis and treatment
10/26/2005EP1587836A2 Cancerous disease modifying antibodies
10/26/2005EP1587835A2 Antibodies specific for plasmacytoid dendritic cells
10/26/2005EP1587834A2 Uses of mammalian cytokine; related reagents
10/26/2005EP1587833A2 Epad, an oocyte specific protein
10/26/2005EP1587828A1 Defensin protins
10/26/2005EP1587825A2 Antigen imitating extracellular areas of membrane proteins of type iii produced from intracellular pathogenic micro-organisms, derived conformational antibodies and the use thereof
10/26/2005EP1587542A1 Use of anti-cd100 antibodies
1 ... 708 709 710 711 712 713 714 715 716 717 718 719 720 721 722 723 724 725 726 727 728 ... 1494